Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation

Psychiatry Res. 1997 Mar 24;69(2-3):155-62. doi: 10.1016/s0165-1781(96)03032-6.

Abstract

In 15 patients with obsessive-compulsive disorder (OCD) and in 15 healthy controls postsynaptic alpha-2-adrenoceptor sensitivity was examined by measuring the growth hormone (GH) response to growth hormone-releasing hormone (GHRH) and to clonidine stimulation. Basal values of GH and somatomedin-C (SMD-C) and mean GH responses to GHRH were the same in patients and controls, thus suggesting that a peripheral pathology of the somatotropic axis should not be present. GH responses to clonidine stimulation were blunted in patients suggesting that post-synaptic alpha-2-adrenoceptors are subsensitive, possibly due to higher than normal noradrenergic secretion.

MeSH terms

  • Adolescent
  • Adrenergic alpha-Agonists / pharmacology*
  • Adult
  • Clonidine / pharmacology*
  • Female
  • Growth Hormone-Releasing Hormone / pharmacology*
  • Human Growth Hormone / blood*
  • Humans
  • Male
  • Middle Aged
  • Obsessive-Compulsive Disorder / physiopathology*
  • Receptors, Adrenergic, alpha-2 / drug effects*
  • Receptors, Adrenergic, alpha-2 / physiology

Substances

  • Adrenergic alpha-Agonists
  • Receptors, Adrenergic, alpha-2
  • Human Growth Hormone
  • Growth Hormone-Releasing Hormone
  • Clonidine